Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
IDEX Corp. (IEX - Snapshot Report) reported diluted earnings per share of 66 cents in the first quarter of 2012 compared with 57 cents in the first quarter of 2011 and 65 cents in the earlier quarter.
Earnings not only beat the Zacks Consensus Estimate of 64 cents per share but also managed to surpass the company’s previously provided guidance range of 62 cents per share to 64 cents per share for the quarter.
Revenues
Net revenues came to $489.4 million, up 14.6% year over year and 1.8% sequentially. This surpassed the Zacks Consensus Estimate of $481 million comprehensively. Orders were up 20% annually to reach $531 million in the first quarter of 2012. Management was quite appeased by the improved orders and ameliorated revenues across all three segments.
The Fluid and Metering Technologies (FMT) segment reported sales of $212.7 million, up 6.4% year over year but down 0.6% sequentially. The Health and Science Technologies (HST) segment revenues came in at $173.8 million, rising 34.5% annually and 3.5% sequentially. The Fire and Safety segment recorded sales of $104.1 million, up 5.3% annually and 37% sequentially.
Margins
Operating margin (excludingre-structuring charges) in the quarter came to 18.3% versus 18.2% in the previous year quarter and 17.8% in the last quarter. This was achieved on the backs of increased sales and efficiency in productivity.
The FMT segment reported improved sales coupled with production efficiencies during the quarter resulting in an operating margin of 22.2%, rising from 21% in the last year quarter and 19.7% sequentially.
The HST segment operating margin came in at 18.3%, falling from 22.8% in the previous year quarter and 19.5% in the fourth quarter of 2011, mainly due to the adverse dilutive effects of acquisitions.
The Fire and Safety products segment recorded an operating margin of 23.3% versus 21.4% in the year-ago quarter and 28.1% in the last quarter. The annual rise was attributable primarily to the vast re-structuring activities implemented during the quarter to increase operational efficiency.
Balance Sheet and Cash Flow
As of March 31, 2012, the company had cash and cash equivalents of $245.5 million, increasing from $230.3 million at the end of the previous quarter. Also, net receivables came in $270.8 million, rising from $252.9 million at the end of the previous quarter. Long-term debt reduced to $769.9 million from $806.4 million at the end of the previous quarter.
Cash provided by operating activities amounted to $58.7 million at the end of the first quarter of 2012 compared to $29.1 million in the previous year quarter. Capital expenditures incurred were $8.5 million versus $11.4 million at the end the first quarter of 2011.
Share Repurchase
During the first quarter of 2012, IDEX repurchased 239,000 shares of its own stock for $10.2 million.
Outlook
IDEX looks quite favorably ahead for its upcoming quarter performance with EPS projections of 70 cents per share – 72 cents per share for the second quarter of 2012.
Management increased EPS expectations from a previous range of $2.74 - $2.82 to a range of $2.80 and $2.85 for full year 2012. Also, organic revenue is projected to be in roughly mid-single digits.
Read the full reports :
Snapshot Report on IEX